Interchange Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304K Sell
3,334
-2,195
-40% -$196K 0.1% 198
2025
Q4
$437K Buy
5,529
+2,227
+67% +$175K 0.08% 220
2025
Q3
$264K Buy
3,302
+814
+33% +$69.4K 0.05% 289
2025
Q2
$226K Buy
2,488
+95
+4% +$8.67K 0.05% 257
2025
Q1
$224K Buy
2,393
+10
+0.4% +$895 0.06% 247
2024
Q4
$217K Buy
2,383
+8
+0.3% +$763 0.08% 229
2024
Q3
$247K Hold
2,375
0.09% 225
2024
Q2
$230K Buy
+2,375
New +$219K 0.08% 235
2021
Q1
Sell
-367
Closed -$31K 385
2020
Q4
$31K Buy
+367
New +$30.3K 0.02% 508

Other funds holding CL

Interchange Capital Partners's CL Position: Q1 2026 in Review

Interchange Capital Partners reduced its Colgate-Palmolive (CL) stake by 40% in Q1 2026, selling an estimated $196K and leaving 3,334 shares worth $304K. The position accounts for 0.1% of the portfolio, ranked #198.

Interchange Capital Partners first reported a position in CL in Q4 2020 and has held it in 9 quarters since. The position peaked at $437K in Q4 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Interchange Capital Partners held 3,334 shares of Colgate-Palmolive worth $304K as of Q1 2026.
  • Interchange Capital Partners sold 2,195 Colgate-Palmolive shares in Q1 2026, an estimated $196K.
  • Colgate-Palmolive made up 0.1% of Interchange Capital Partners's portfolio in Q1 2026, its #198 holding.
  • Interchange Capital Partners first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 9 quarters since.
  • Interchange Capital Partners's Colgate-Palmolive position peaked at $437K in Q4 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.